Transcriptome profiling of CTLs regulated by rapamycin using RNA-Seq

Area of Science:

• Immunology
• Molecular Biology
• Cellular Biology

Background:

• Cytotoxic T lymphocyte (CTL) memory programming is influenced by inflammatory cytokines and regulated by the mammalian target of rapamycin (mTOR) pathway.
• Inhibition of mTOR during CTL activation enhances memory, but the underlying molecular mechanisms require elucidation.

Purpose of the Study:

• To investigate the molecular mechanisms by which mTOR inhibition enhances CTL memory formation using high-throughput RNA-Seq.
• To identify specific genes and cellular functions affected by rapamycin treatment in mouse CTLs.

Main Methods:

• High-throughput RNA sequencing (RNA-Seq) was employed to analyze gene expression profiles in mouse CTLs treated with rapamycin.
• Quantitative PCR (qPCR) was used to validate the RNA-Seq findings.

Main Results:

• Rapamycin treatment resulted in differential expression of 184 transcripts, corresponding to 128 annotated genes.
• The majority of affected genes (114 out of 128) were downregulated, with 50 genes directly implicated in cell death and survival (apoptosis).
• Genes related to cell migration, such as CD62L, were also affected, and downregulation of transcriptional regulators was predicted.

Conclusions:

• mTOR inhibition by rapamycin enhances CTL survival into memory, potentially by downregulating multiple genes involved in apoptosis and migration.
• These findings provide molecular insights into the enhancement of CTL memory by mTOR inhibition.